Skip to main content

54 452 (Lithium Carbonate 300 mg)

Pill with imprint 54 452 is White, Round and has been identified as Lithium Carbonate 300 mg. It is supplied by Hikma Pharmaceuticals PLC.

Lithium is used in the treatment of bipolar disorder; schizoaffective disorder; mania and belongs to the drug class antimanic agents. There is positive evidence of human fetal risk during pregnancy. Lithium 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 54 452

Lithium carbonate 300 mg 54 452
Lithium carbonate 300 mg 54 452
Lithium carbonate 300 mg 54 452
Lithium carbonate 300 mg 54 452
Lithium carbonate 300 mg 54 452 Front
Lithium carbonate 300 mg 54 452 Back

Lithium Carbonate

Imprint
54 452
Strength
300 mg
Color
White
Size
10.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Antimanic agents
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Hikma Pharmaceuticals PLC
Inactive Ingredients
calcium stearate, microcrystalline cellulose, povidone k30, sodium lauryl sulfate, sodium starch glycolate type A potato, water

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00054-4527 Roxane Laboratories, Inc.
00054-8528 Roxane Laboratories, Inc.

Get help with Imprint Code FAQs.

Related images for "54 452"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.